Grzegorz Zieliński

Grzegorz Zielinski
Grzegorz Zieliński
Born1996 (age 29–30)
CitizenshipPoland
EducationMedical University of Lublin
Known forResearch on Bruxism, Temporomandibular Disorders, Epidemiology, Medical Statistics
Scientific career
FieldsPhysiotherapist, Biostatistician
Thesis (2024)

Grzegorz Zieliński (born 1996[1]) is a Polish physiotherapist, epidemiologist, and medical statistician specializing in research methodology in the medical sciences, particularly effect size analysis and sample size planning in clinical studies.

Biography

From 2015 to 2020, he studied physiotherapy at the Medical University of Lublin, Poland.[2] In 2024, he defended his doctoral dissertation entitled “Myopia and the Bioelectrical Activity of the Masticatory Muscles”.[2][3] The subject of his doctoral dissertation and his research focus at the time concerned the relationship between visual impairments and changes within the musculature of the craniofacial system.[4][5][6]

From 2021 to 2022, he completed postgraduate Master of Business Administration (MBA) studies at Wyższa Szkoła Biznesu – National-Louis University.[2]

Scientific activity

He is the author and co-author of scientific publications in the fields of physiotherapy, dentistry, and clinical research methodology. He has authored more than 110 publications, with an H-index of 21 (2026).[7]

Epidemiological and statistical activity

Application of effect size measures in medical research

In his scientific work, he focuses on the application of effect size measures in medical research, particularly indices such as Cohen's d, Hedges’ g, and Pearson's correlation coefficient r.

He has published studies on the interpretation of effect sizes and sample size planning (statistical power analysis) in research within physiotherapy, dentistry, and pain studies. In these publications, he emphasized the importance of appropriate clinical study design in improving the reliability and reproducibility of scientific results.[8][9][10]

He has collaborated with Prof. Mieszko Więckiewicz on a publication concerning the use of effect size measures and sample size planning in dental research.[10] The article was published in the Polish scientific journal Dental and Medical Problems.

Comparison with classical Cohen's benchmarks

In some of his works, he indicated that the interpretation of effect size magnitude may vary depending on the field of medical research (Tables 1 and 2), which may require an approach different from the conventional thresholds proposed by Jacob Cohen.

For example, in pain research, medium effect sizes may be observed at lower values of Cohen's d than in the classical statistical interpretation, whereas in certain dental studies, large effect sizes may exceed the standard threshold of 0.8 (Table 1).

The interpretative proposals presented in these works relate to the specific characteristics of results obtained in particular fields of clinical research and are methodological in nature.[8][10][9]

Table 1. Comparison of Cohen's d effect size thresholds versus those proposed by Zieliński.
Effect Size Cohen's d[11] Pain research[8] Dental research[10] Physiotherapy research[9]
Small 0.2 0.1 0.1 0.1
Medium 0.5 0.3 0.4 0.4
Large 0.8 0.7 0.9 0.8
Table 2. Comparison of Effect Size: Pearson's Linear Correlation Coefficient vs. the Classification Proposed by Zieliński.
Effect Size Pearson's Linear Correlation Coefficient[11] Pain research[8] Dental research[10] Physiotherapy research[9]
Small 0.1 0.1 0.2 0.3
Medium 0.3 0.3 0.4 0.5
Large 0.5 0.4 0.7 0.6

Zieliński additionally derived discipline-specific interpretive thresholds for odds ratios (OR), relative risk (RR), and the η² and ηp² coefficients in physiotherapy, based on algebraic transformations of Cohen's d.[12] The model also incorporated varying baseline risk levels (p0), enabling the derivation of differentiated RR thresholds (Table 3).

Table3. Effect Size Thresholds for Physiotherapy Research Proposed by Zieliński.[12]
Effect Size OR RR (p0 =

0.1)

RR (p0 =

0.2)

RR (p0 =

0.5)

η2/ηp2
Small 1.20 1.18 1.17 1.09 0.003
Medium 2.07 1.95 1.72 1.35 0.039
Large 4.27 3.22 2.58 1.62 0.138

Epidemiology and medical prognosis

Dr Zieliński was among the first researchers to highlight the epidemiological heterogeneity of stomatognathic system disorders depending on geographic region, indicating significant differences in the prevalence of these conditions among populations living in different parts of the world.[13][14][15] These analyses emphasized the importance of environmental and cultural factors as well as healthcare systems in shaping the epidemiological profile of temporomandibular disorders[13] and bruxism.[14] In 2026, while collaborating with Prof. Wieckiewicz, Dr Zieliński was the first to calculate the prevalence of oral and facial pain for Africa and Australia, enabling a more comprehensive understanding of regional differences in its occurrence.[16] This had not been possible in earlier analyses[13][14][17] or in studies by other researchers[18][19] (Table 4).

In his work, he also presented one of the earliest epidemiological forecasts concerning the future global prevalence of temporomandibular disorders.[17] his projection suggested that the prevalence of these disorders could increase to approximately 44% of the world's population by 2050, a trend attributed, among other factors, to population ageing, increased exposure to stress-related factors, and changes in lifestyle.[20]

Table 4. Epidemiology of Medical Conditions Estimated by Dr. Zieliński.
TMD

(%)[13]

Awake bruxism

(%)[14]

Sleep Bruxism

(%)[14]

Oral Pain

(%)[16]

Africa - - - 31
Asia 33 25 19 25
Australia - - - 21
Europe 29 18 21 16
North America 26 - 31 13
South America 47 30 25 24
Globally 34 23 21 21

Other scientific activity

Dr. Zieliński is the author of, among others, a textbook on sports medicine (published in Polish).[21] He has also completed more than 600 scientific peer reviews (2026).[22] In addition, he served as co-editor of the special issue Bruxism and Temporomandibular Disorders: Current Advances and Future Challenges together with Eiji Tanaka from Japan.[23]

He is a co-inventor of an orthopedic device designed for cervical spine rehabilitation that is protected under European patent protection.[24]

Dr. Grzegorz Zieliński is a co-author of novel electromyographic indices used to assess masticatory muscle activity, including the Functional Clenching Activity Index (FCAI), Functional Clenching Symmetry Index (FCSI), and Functional Opening Symmetry Index (FOSI).[25]

Exploratory activity

In his publications, he has also addressed historical and exploratory subjects. Among other topics, he discussed the third British Mount Everest expedition of 1924, which may have resulted in the first successful ascent of the summit in history. On this subject, he published a scientific paper entitled Who Won the fight for Everest? – The Centenary of the Death of George Mallory and Andrew Irvine.[26]

Furthermore, he is the author of two historical books (published in Polish), which have not yet been translated into other languages.[27][28]

References

  1. ↑ "Biblioteka Narodowa - autor Grzegorz Zieliński". katalogi.bn.org.pl.
  2. 1 2 3 "Polska Platforma Medyczna - Grzegorz Zieliński".
  3. ↑ Grzegorz, Zieliński (2023). "Biblioteka Pracowników Uniwersytetu Medycznego w Lublinie - Grzegorz Zieliński".
  4. ↑ Grzegorz Zieliński, Anna Matysik-Woźniak, Anna Pankowska, Radosław Pietura, Robert Rejdak, Kamil Jonak (2023-06-20). "High Myopia and Thickness of Extraocular and Masticatory Muscles—7T MRI, Preliminary Study". Journal of Clinical Medicine. 12 (12): 4166. doi:10.3390/jcm12124166. PMC 10299053. PMID 37373859.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ↑ Grzegorz Zieliński, Michał Baszczowski, Maria Rapa, Anna Matysik-Woźniak, Magdalena Zawadka, Jacek Szkutnik, Piotr Gawda, Robert Rejdak, Piotr Majcher, Michał Ginszt (2022-08-16). Aneta Wieczorek (ed.). "The Axial Length of the Eyeball and Bioelectrical Activity of Masticatory and Neck Muscles: A Preliminary Report". Pain Research and Management. 2022: 1–9. doi:10.1155/2022/6115782. PMC 9398725. PMID 36017253.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ↑ Grzegorz Zieliński, Marcin Wójcicki, Maria Rapa, Anna Matysik-Woźniak, Michał Baszczowski, Michał Ginszt, Monika Litko-Rola, Jacek Szkutnik, Ingrid Różyło-Kalinowska, Robert Rejdak, Piotr Gawda (2022-04-13). "Masticatory Muscle Thickness and Activity Correlates to Eyeball Length, Intraocular Pressure, Retinal and Choroidal Thickness in Healthy Women versus Women with Myopia". Journal of Personalized Medicine. 12 (4): 626. doi:10.3390/jpm12040626. PMC 9027064. PMID 35455742.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ↑ "Grzegorz Zieliński". scholar.google.pl.
  8. 1 2 3 4 Grzegorz Zieliński (January 2026). "Getting to Know Pain Effect Sizes—Guidelines for Effect Size and Sample Size in Global Pain Research". Archives of Physical Medicine and Rehabilitation. pp. 726–733. doi:10.1016/j.apmr.2026.01.006. PMID 41554392.
  9. 1 2 3 4 Grzegorz Zieliński (December 2025). "Effect Size Guidelines for Individual and Group Differences in Physiotherapy". Archives of Physical Medicine and Rehabilitation. pp. 1844–1849. doi:10.1016/j.apmr.2025.05.013. PMID 40543698.
  10. 1 2 3 4 5 Grzegorz Zieliński, Mieszko Więckiewicz (2025-10-28). "New effect size and sample size guidelines in dentistry". Dental and Medical Problems. pp. 907–917. doi:10.17219/dmp/210478. PMID 41159861.
  11. 1 2 Jacob Cohen (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, publishers. ISBN 978-0-203-77158-7.
  12. 1 2 Zieliński, Grzegorz (2026-05-19). "Defining Effect Size Thresholds for OR, RR, and η² in Physiotherapy Studies". Stats. 9 (3): 49. doi:10.3390/stats9030049. ISSN 2571-905X.
  13. 1 2 3 4 Grzegorz Zieliński, Beata Pająk-Zielińska, Michał Ginszt (2024-02-28). "A Meta-Analysis of the Global Prevalence of Temporomandibular Disorders". Journal of Clinical Medicine. 13 (5): 1365. doi:10.3390/jcm13051365. PMC 10931584. PMID 38592227.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  14. 1 2 3 4 5 Grzegorz Zieliński, Agnieszka Pająk, Marcin Wójcicki (2024-07-22). "Global Prevalence of Sleep Bruxism and Awake Bruxism in Pediatric and Adult Populations: A Systematic Review and Meta-Analysis". Journal of Clinical Medicine. 13 (14): 4259. doi:10.3390/jcm13144259. PMC 11278015. PMID 39064299.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. ↑ Grzegorz Zieliński, Beata Pająk-Zielińska, Agnieszka Pająk, Marcin Wójcicki, Monika Litko-Rola, Michał Ginszt (2025-03-18). "Global co-occurrence of bruxism and temporomandibular disorders: A meta-regression analysis". Dental and Medical Problems. 62 (2): 309–321. doi:10.17219/dmp/201376. PMID 40099938.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  16. 1 2 Grzegorz Zieliński, Michał Ginszt, Agata Ginszt, Marcin Wójcicki, Monika Litko-Rola, Mieszko Więckiewicz (2026-02-25). "Meta-analysis of the global prevalence of oral and facial pain". Dental and Medical Problems. pp. 219–231. doi:10.17219/dmp/214956. PMID 41738982.{{cite web}}: CS1 maint: multiple names: authors list (link)
  17. 1 2 Grzegorz Zieliński (2025-06-20). "Quo Vadis Temporomandibular Disorders? By 2050, the Global Prevalence of TMD May Approach 44%". Journal of Clinical Medicine. 14 (13): 4414. doi:10.3390/jcm14134414. PMC 12249499. PMID 40648789.
  18. ↑ Alqutaibi, A. Y.; Alhammadi, M. S.; Hamadallah, H. H.; Altarjami, A. A.; Malosh, O. T.; Aloufi, A. M.; Alkahtani, L. M.; Alharbi, F. S.; Halboub, E.; Almashraqi, A. A. (2025). "Global prevalence of temporomandibular disorders: a systematic review and meta-analysis". Journal of Oral & Facial Pain and Headache. 39 (2): 48–65. doi:10.22514/jofph.2025.025. PMC 12531580. PMID 41070533.
  19. ↑ Lígia Figueiredo Valesan, Cecília Doebber Da-Cas, Jéssica Conti Réus, Ana Cristina Scremin Denardin, Roberto Ramos Garanhani, Daniel Bonotto, Eduardo Januzzi, Beatriz Dulcineia Mendes de Souza (February 2021). "Prevalence of temporomandibular joint disorders: a systematic review and meta-analysis". Clinical Oral Investigations. 25 (2): 441–453. doi:10.1007/s00784-020-03710-w. PMID 33409693.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  20. ↑ Grzegorz Zieliński (2025-06-20). "Quo Vadis Temporomandibular Disorders? By 2050, the Global Prevalence of TMD May Approach 44%". Journal of Clinical Medicine. 14 (13): 4414. doi:10.3390/jcm14134414. PMC 12249499. PMID 40648789.
  21. ↑ Kuśmierczyk, Urszula; Gawda, Piotr; Kuźmicz, Maksymilian; Ginszt, Michał; Byś, Aleksandra; Zieliński, Grzegorz; Zakład Medycyny Sportowej (Uniwersytet Medyczny ; Lublin); Zakład Rehabilitacji i Fizjoterapii (Uniwersytet Medyczny ; Lublin); Kolegium Międzyobszarowych Indywidualnych Studiów Humanistyczno-Społecznych (Katolicki Uniwersytet Lubelski Jana Pawła II), eds. (2020). Sporty ekstremalne: adaptacja do nieznanego. Lublin: Uniwersytet Medyczny w Lublinie. ISBN 978-83-62606-74-0. OCLC 1243002441.
  22. ↑ "Web of Science". Retrieved 2026-05-24.
  23. ↑ "Bruxism and Temporomandibular Disorders: Current Advances and Future Challenges".
  24. ↑ "PL248266B1 Support for cervical spine rehabilitation".
  25. ↑ Ginszt, Michał; Zieliński, Grzegorz (2021-04-01). "Novel Functional Indices of Masticatory Muscle Activity". Journal of Clinical Medicine. 10 (7): 1440. doi:10.3390/jcm10071440. ISSN 2077-0383. PMC 8036463. PMID 33916147.
  26. ↑ Grzegorz Zieliński (2025). "Who won the fight for Everest? – the century of the death of George Mallory and Andrew Irvine". Sport i Turystyka. Środkowoeuropejskie Czasopismo Naukowe. 8 (1): 11–34. doi:10.16926/sit.2025.01.01.
  27. ↑ Gralewski, Leszek; Zieliński, Grzegorz (2016). Skansen: odkrywanie straconego czasu. Toruń: Wydawnictwo Adam Marszałek. ISBN 978-83-8019-366-6.
  28. ↑ Zieliński, Grzegorz (2016). "Cichy". Lublin: Norbertinum Wydawnictwo, Drukarnia, Księgarnia. ISBN 978-83-7222-583-2.